Literature DB >> 24670326

Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia.

J Liu1, Y Xu1, H Zhang1, X Gao1, H Fan1, G Wang1.   

Abstract

Hyperhomocysteinemia (HHcy) is an independent risk factor for coronary artery disease. Chronic HHcy induces coronary endothelial injury, and homocysteine (Hcy) inhibits insulin sensitivity by inducing endoplasmic reticulum stress in adipose tissue. However, the combined effects of chronic HHcy and hypertension on coronary artery endothelial function have still remained unclear. Fifty-one patients with essential hypertension (HT) were recruited, and were divided into nHT group (without HHcy) and H-type HT group (with HHcy). Forty healthy subjects were enrolled as controls. We assessed coronary artery endothelial function by coronary flow velocity reserve (CFVR). Hcy levels were significantly higher (15.60±6.58 vs 13.08±4.13 μmol l(-1), P<0.05), whereas CFVR values were significantly lower in the HT patients than in the control group (2.88±0.70 vs 3.23±0.54, P<0.05). Hcy levels were negatively correlated with CFVR value (r=-0.578, P<0.01, 95% confidence interval -0.085 to -0.046). The homeostasis model assessment-insulin resistance values were significantly higher (3.92±2.16 vs 2.72±1.50, P<0.05) , whereas CFVR values were significantly lower in H-type HT group than in nHT group (2.31±0.31 vs 3.25±0.62, P<0.01). Coronary artery endothelial function may be impaired in essential hypertensive patients with HHcy, and insulin resistance induced by HHcy may contribute to this damage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24670326     DOI: 10.1038/jhh.2014.22

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  31 in total

1.  Methionine-induced homocysteinemia impairs endothelial function in hypertensives: the role of asymmetrical dimethylarginine and antioxidant vitamins.

Authors:  Dimitris Tousoulis; George Bouras; Charalambos Antoniades; Kyriakoula Marinou; Nikolaos Papageorgiou; Antigoni Miliou; George Hatzis; Elli Stefanadi; Costas Tsioufis; Christodoulos Stefanadis
Journal:  Am J Hypertens       Date:  2011-04-14       Impact factor: 2.689

Review 2.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

3.  Homocysteine and reclassification of cardiovascular disease risk.

Authors:  Vikas Veeranna; Sandip K Zalawadiya; Ashutosh Niraj; Jyotiranjan Pradhan; Brian Ference; Robert C Burack; Sony Jacob; Luis Afonso
Journal:  J Am Coll Cardiol       Date:  2011-08-30       Impact factor: 24.094

4.  Effects of ghrelin on homocysteine-induced dysfunction and inflammatory response in rat cardiac microvascular endothelial cells.

Authors:  Dongjuan Wang; Haichang Wang; Peng Luo; Andrew Hwang; Dongdong Sun; Yabin Wang; Zheng Zhang; Nan Liu; Shenxu Wang; Chengxiang Li; Feng Cao
Journal:  Cell Biol Int       Date:  2012-06-01       Impact factor: 3.612

5.  Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression.

Authors:  Jui-Kun Chiang; Mao-Lin Sung; Hong-Ren Yu; Hsin-I Chang; Hsing-Chun Kuo; Tzung-Chieh Tsai; Chia-Kuang Yen; Cheng-Nan Chen
Journal:  J Cell Physiol       Date:  2011-04       Impact factor: 6.384

6.  Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.

Authors:  Liyun He; Hui Zeng; Fuwang Li; Jieli Feng; Shan Liu; Jinbo Liu; Jie Yu; Jieming Mao; Tianpei Hong; Alex F Chen; Xian Wang; Guang Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-09-21       Impact factor: 4.310

7.  Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.

Authors:  Guang Wang; Jie-Ming Mao; Xian Wang; Fu-Chun Zhang
Journal:  Chin Med J (Engl)       Date:  2004-11       Impact factor: 2.628

8.  Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance.

Authors:  M Buysschaert; A S Dramais; P E Wallemacq; M P Hermans
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

9.  Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.

Authors:  Ting-Ting Yan; Qian Li; Xuan-Hong Zhang; Wei-Kang Wu; Juan Sun; Lin Li; Quan Zhang; Hong-Mei Tan
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-11       Impact factor: 2.557

10.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

View more
  9 in total

Review 1.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

2.  Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome.

Authors:  Zhenhong Fu; Geng Qian; Hao Xue; Jun Guo; Lian Chen; Xia Yang; Mingzhi Shen; Wei Dong; Yundai Chen
Journal:  Clin Interv Aging       Date:  2015-09-15       Impact factor: 4.458

3.  Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism.

Authors:  Ning Yang; Zhi Yao; Li Miao; Jia Liu; Xia Gao; Hui Fan; Yanjin Hu; Heng Zhang; Yuan Xu; Aijuan Qu; Guang Wang
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

4.  Hyperhomocysteinemia is associated with decreased apolipoprotein AI levels in normal healthy people.

Authors:  Ying Wang; Jia Liu; Yuliang Jiang; Heng Zhang; Song Leng; Guang Wang
Journal:  BMC Cardiovasc Disord       Date:  2016-01-13       Impact factor: 2.298

5.  Relationship between lactate dehydrogenase and albuminuria in Chinese hypertensive patients.

Authors:  Xiaoqi Cai; Tingjun Wang; Chaoyi Ye; Guoyan Xu; Liangdi Xie
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-07       Impact factor: 3.738

6.  Risk factors for new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis.

Authors:  Mancheng Xia; Haosen Yang; Xunan Tong; Hongjie Xie; Fan Cui; Weibing Shuang
Journal:  J Diabetes Investig       Date:  2020-07-12       Impact factor: 4.232

7.  Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study.

Authors:  Ning Yang; Zhi Yao; Li Miao; Jia Liu; Xia Gao; Yuan Xu; Guang Wang
Journal:  Lipids Health Dis       Date:  2016-07-26       Impact factor: 3.876

8.  Potential harmful correlation between homocysteine and low-density lipoprotein cholesterol in patients with hypothyroidism.

Authors:  Xuejie Dong; Zhi Yao; Yanjin Hu; Ning Yang; Xia Gao; Yuan Xu; Guang Wang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  Serum vascular endothelial growth factor level is elevated in patients with impaired glucose tolerance and type 2 diabetes mellitus.

Authors:  Xiaomeng Sun; Heng Zhang; Jia Liu; Guang Wang
Journal:  J Int Med Res       Date:  2019-09-23       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.